Software Effective Solutions “MEDCANA” (OTC: SFJW) Begins Full Crop Cycle Testing and Advances Infrastructure Development in Colombia


Ryan Allway

April 19th, 2023

News, Top News, Top Story


New Orleans, Louisiana –News Direct– Software Effective Solutions Corp.

 

McapMediaWire — Software Effective Solutions (OTC: SFWJ) (“The Company”, “SFWJ”), doing business as MedCana, is pleased to announce that it has begun full crop cycle testing across all five of its recently acquired companies in Medellín, Colombia. The goal of this testing phase is to train personnel, observe crop behavior, and ensure production processes work seamlessly. These tests are being conducted in smaller, controlled greenhouse environments before being scaled up to full production.

 

In addition to the crop cycle testing, MedCana has made significant progress in infrastructure development. Last week, the company finalized road and rainwater management systems, paving the way for earthmoving equipment to begin terracing and preparation for the first phase of the project.

 

“We are extremely happy with the progress we’ve made in the construction and development of our five companies in Colombia. We see no obstacles and remain satisfied with all results,” said Gabriel Diaz, CEO of SFWJ.

 

MedCana’s commitment to meticulous analysis and testing of all variables, including wind currents, humidity, soil, pests, and more, is reflected in the success of its initial infrastructure analysis, which has covered geological, hydrological, and environmental factors.

 

The recent acquisition of Tokan Corp’s assets, a software company focused on creating an ERP platform for the cannabis industry, and Eko2O S.A.S., a greenhouse design and distribution company, has positioned MedCana for explosive growth in the region. The expertise and industry knowledge of Juan Ricardo Velez, CEO of Eko2O, has also contributed to dramatically decreasing costs for MedCana’s subsidiaries in the region.

 

ABOUT SFWJ: Software Effective Solutions/MedCana is a global infrastructure and holding company in the cannabis industry. With a recent acquisition of a software company, MedCana expanded its offering to provide traceability from plant to product. The company’s initial focus is on developing clients and companies in Latin America, with an emphasis on Colombia, and forming partnerships with laboratories, research facilities, and hospitals worldwide.

 

As MedCana moves forward with its expansion plans, the company remains committed to delivering on its promise of building a solid foundation for future growth, ensuring the highest quality pharmaceutical cannabis products and raw material for its customers, and maximizing shareholder value.

 

SAFE HARBOR STATEMENT

This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company’s control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Contact:

Jose Gabriel Diaz, CEO

www.medcana.net

info@medcana.co

Contact Details

MedCana

info@medcana.co

Company Website

https://www.medcana.net/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading